OpenLB
Open Library of Bioscience
Advanced Search
Wiener medizinische Wochenschrift (1946)
Jun, 2010;160 (11-12): 264-269.

[Polypharmacy is of major concern in cardiology].

Peter Dovjak, Ulrike Sommeregger, Ronald Otto, Regina E Roller, Birgit Böhmdorfer, Bernhard Iglseder, Ursula Benvenuti-Falger, Monika Lechleitner, Markus Gosch
Author Information
  1. Peter Dovjak: Abteilung für Akutgeriatrie/Remobilisation, Landeskrankenhaus Gmunden, Gmunden, Austria.
  2. Ulrike Sommeregger: Abteilung für Akutgeriatrie, Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhügel, Wien, Austria.
  3. Ronald Otto: Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz, Austria.
  4. Regina E Roller: Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz, Austria.
  5. Birgit Böhmdorfer: Anstaltsapotheke, Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhügel, Wien, Austria.
  6. Bernhard Iglseder: Universitätsklinik für Geriatrie, Paracelsus Medizinische Privatuniversität, Salzburg, Austria.
  7. Ursula Benvenuti-Falger: Abteilung für Innere Medizin und Akutgeriatrie, Landeskrankenhaus Hochzirl, Zirl, Austria.
  8. Monika Lechleitner: Abteilung für Innere Medizin und Akutgeriatrie, Landeskrankenhaus Hochzirl, Zirl, Austria.
  9. Markus Gosch: Abteilung für Innere Medizin und Akutgeriatrie, Landeskrankenhaus Hochzirl, Zirl, Austria. markus.gosch@tilak.at.
PMID: 20640922 DOI: 10.1007/s10354-010-0784-3

Abstract

Quality improvement in cardiology over the past decade focused on management of acute coronary syndrome with invasive and innovative medical therapies, optimizing treatment of congestive heart failure and the development of repair procedures in valvular heart disease. On the other hand cardiologist and the attendant physicians are confronted with changes in the characteristics of patients in the light of demographic facts. Comorbidity and polypharmacy raise the need for clear concepts. Therapeutic and diagnostic tools of geriatric medicine may help in that context.

References

  1. Am Heart J. 2009 May;157(5):825-6 [PMID: 19376307]
  2. Ann N Y Acad Sci. 2004 Jun;1019:106-10 [PMID: 15247001]
  3. Am Heart J. 2007 Jan;153(1):1-3 [PMID: 17174625]
  4. J Am Geriatr Soc. 2003 Apr;51(4):476-82 [PMID: 12657066]
  5. Clin Geriatr Med. 1987 Feb;3(1):1-15 [PMID: 3545421]
  6. JAMA. 2005 Mar 16;293(11):1348-58 [PMID: 15769968]
  7. J Clin Epidemiol. 1992 Oct;45(10):1045-51 [PMID: 1474400]
  8. Arch Intern Med. 2003 Dec 8-22;163(22):2716-24 [PMID: 14662625]
  9. Clin Pharmacol Ther. 1981 Aug;30(2):239-45 [PMID: 7249508]
  10. J Aging Health. 2005 Apr;17(2):239-56 [PMID: 15750053]
  11. JAMA. 2006 Aug 9;296(6):637-8 [PMID: 16896095]
  12. Am Heart J. 2008 Nov;156(5):816-25, 825.e1 [PMID: 19061693]
  13. Europace. 2004 Nov;6(6):467-537 [PMID: 15519256]
  14. Am J Cardiol. 2009 Jun 1;103(11):1616-21 [PMID: 19463525]

MeSH Term

Aged
Aged, 80 and over
Bradycardia
Cardiovascular Agents
Drug Interactions
Drug Therapy, Combination
Frail Elderly
Heart Diseases
Humans
Long QT Syndrome
Prescription Drugs
Syncope
Tachycardia

Chemicals

Cardiovascular Agents
Prescription Drugs
Case Reports English Abstract Journal Article Review

Word Cloud

Created with Highcharts 10.0.0heartQualityimprovementcardiologypastdecadefocusedmanagementacutecoronarysyndromeinvasiveinnovativemedicaltherapiesoptimizingtreatmentcongestivefailuredevelopmentrepairproceduresvalvulardiseasehandcardiologistattendantphysiciansconfrontedchangescharacteristicspatientslightdemographicfactsComorbiditypolypharmacyraiseneedclearconceptsTherapeuticdiagnostictoolsgeriatricmedicinemayhelpcontext[Polypharmacymajorconcerncardiology]

Similar Articles

Cited By